Pharmarise Holdings CorporationJP:2796

Market cap
¥6.4B
P/E ratio
22.6x
2013/052014/052015/052016/052017/052018/052019/052020/052021/052022/052023/052024/052025/05
Cash and cash equivalents -3,6433,8843,3443,7453,6534,4034,4724,6043,9914,7427,1504,911
Inventories-9351,0871,9012,1862,0502,0592,5772,5122,2372,2252,5764,065
Total current assets-8,5588,2589,0728,3619,1229,60110,67610,54610,87811,37213,73713,239
Property, plant and equipment, net-6,5066,6466,9167,0116,5036,2906,3326,4346,3556,0106,1987,209
Marketable securities, non-current -6406066134414484446861608267339
Total non-current assets-16,29715,94516,58016,16915,13514,60814,52414,17512,86612,04815,74818,684
Total assets -24,87924,22625,66724,54024,26524,21725,20624,72423,74623,42129,48631,924
Short-term debt-4043---20-2404401,5903,049
Long-term debt, current -2,8712,5633,0842,6983,2442,5772,6812,5382,2762,0082,6552,639
Total current liabilities-10,11210,62510,7369,80110,7699,34710,0369,3928,4779,83510,68811,988
Long-term debt, non-current -7,3176,0706,8857,0446,1756,1506,0375,9505,6035,2169,65411,053
Total non-current liabilities-9,1387,7908,6948,8387,8709,2509,2239,0008,5706,59811,35513,017
Total liabilities -19,25118,41519,43018,63918,64018,59719,25918,39217,04716,43322,04325,005
Common stock and paid-in capital -2,3982,4012,3182,3342,4262,5362,6662,7272,8032,8514,1384,147
Retained earnings-3,0543,1923,1273,0082,8522,7493,1973,4943,8114,0143,5302,938
Stockholders' equity4,4595,6295,8116,2375,9005,6245,6195,9466,3316,6996,9877,4426,918